KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Oscar Health (OSCR) Non Operating Income (2021 - 2025)

Historic Non Operating Income for Oscar Health (OSCR) over the last 5 years, with Q4 2025 value amounting to -$20.0 million.

  • Oscar Health's Non Operating Income fell 2955735.29% to -$20.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$23.3 million, marking a year-over-year decrease of 2212761.9%. This contributed to the annual value of -$23.3 million for FY2025, which is 2212761.9% down from last year.
  • Per Oscar Health's latest filing, its Non Operating Income stood at -$20.0 million for Q4 2025, which was down 2955735.29% from -$3.2 million recorded in Q3 2025.
  • In the past 5 years, Oscar Health's Non Operating Income registered a high of $3.3 million during Q3 2022, and its lowest value of -$20.0 million during Q4 2025.
  • Over the past 5 years, Oscar Health's median Non Operating Income value was -$872000.0 (recorded in 2024), while the average stood at -$1.7 million.
  • Its Non Operating Income has fluctuated over the past 5 years, first surged by 55338.16% in 2024, then plummeted by 2955735.29% in 2025.
  • Oscar Health's Non Operating Income (Quarter) stood at -$1.2 million in 2021, then surged by 211.49% to $1.3 million in 2022, then dropped by 21.58% to $1.0 million in 2023, then crashed by 93.52% to $68000.0 in 2024, then crashed by 29557.35% to -$20.0 million in 2025.
  • Its last three reported values are -$20.0 million in Q4 2025, -$3.2 million for Q3 2025, and $2.8 million during Q2 2025.